A versatile drug delivery system targeting senescent cells
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Senescent cells accumulate in multiple aging‐associated diseases, and eliminating these cells has recently emerged as a promising therapeutic approach. Here, we take advantage of the high lysosomal β‐galactosidase activity of senescent cells to design a drug delivery system based on the encapsulation of drugs with galacto‐oligosaccharides. We show that gal‐encapsulated fluorophores are preferentially released within senescent cells in mice. In a model of chemotherapy‐induced senescence, gal‐encapsulated cytotoxic drugs target senescent tumor cells and improve tumor xenograft regression in combination with palbociclib. Moreover, in a model of pulmonary fibrosis in mice, gal‐encapsulated cytotoxics target senescent cells, reducing collagen deposition and restoring pulmonary function. Finally, gal‐encapsulation reduces the toxic side effects of the cytotoxic drugs. Drug delivery into senescent cells opens new diagnostic and therapeutic applications for senescence‐associated disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One approach stems from the increase in lysosomal mass and senescence-associated β-galactosidase activity in many senescent cells, whereby galacto-oligosaccharide-coated nanoparticles and β-galactosidase-activated prodrugs appear to eliminate at least some of these cells92,93.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“Nanoparticles containing either fluorophores or cytotoxic agents coated with galacto-oligosaccharides were found to preferentially deliver cytotoxic cargo to senescent cells because of the higher level of SA-β-gal activity in these cells218.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [218]
The cited source says what the claim attributes to it.
In the citing paper
“A senescence transcriptional signature could enable rapid detection of senescent cells, and multiple such gene sets have been described132–136,139.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“Galacto-oligosaccharide encapsulated nanoparticles (GalNP) containing cytotoxic or senolytic drugs (Muñoz-Espín et al. 2018) and galactose-derived prodrugs display senolytic properties (González-Gualda et al. 2020; Guerrero et al. 2020)”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Muñoz-Espín et al. 2018
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Spatial omics has not yet been used extensively for senescence research but is in development132–136.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
InfluentialThe Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialUltrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialOrdered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275 · cited 4×
“For the synthesis of the mesoporous silica MCM-41 scaffolds (Kresge et al, 1992), N-cetyltrimethylammonium bromide (CTAB, Sigma, #H6269) was first dissolved in 480 ml of deionized water at 2.74 mM.”
BackgroundMethodInfluentialTrapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · cited 1×
“In this regard, it is relevant to mention that macrophages are known to metabolize nanoparticles (Wilhelm et al, 2016) and can present SAbGal activity without actually being senescent (Hall et al, 2017).”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 1×
“Published under the terms of the CC BY 4.0 license EMBO Molecular Medicine 10: e9355 | 2018 1 of 18 processes associated with chemotherapy, and extends longevity (Baker et al, 2016; Childs et al, 2016; Demaria et al, 2017).”
MethodInfluentialCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citationThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 3×
“Importantly, senescent cells present vulnerabilities to particular small molecule inhibitors, known as “senolytics”, that trigger apoptosis preferentially in senescent cells (Zhu et al, 2015).”
Background
Cited by
Items 301–339 of 339
Willobee, B. A., Gaidarski, A. A., Dosch, A. R., Castellanos, J. A., Dai, X., Mehra, S., Messaggio, F., Srinivasan, S., VanSaun, M. N., Nagathihalli, N. S., et al. (2023) · doi:10.1158/1535-7163.c.6543223.v1
Baker, A. G., Ou, H., Hartono, M., Bistrović, A., Brown, E. L., Joseph, J., Golinska, M. A., Sanghera, C., González‐Gualda, E., Macías, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.12.548691
Self-citationThe Aging of Cells: Cellular Senescence and Implications for Age-Related Diseases
Kim, A., & Yoo, J. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i3.4847
¿Combatir la senescencia para un envejecimiento saludable?
Resano, M. M. (2024) · doi:10.18567/sebbmdiv_r.202403
Resolving chromatin interaction and transcriptional networks in mammalian nuclei
Zhu, Y. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10618
Bedeutet älter werden ein Rezidiv zu bekommen? Aging richtig einschätzen
Klinge, U. (2024) · Springer eBooks · doi:10.1007/978-3-662-68686-7_18
Vardon, A., Haston, S., Guiho, R., Carvahlo, D., Carter, R., Boult, J. K. R., Gharai, D., Santhakumar, D., Cloete, I., Gray, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.20.629607 · Cited by 1
Self-citationTargeting the Senescent Tumor Microenvironment to Sensitize Immunotherapy
Sun, W. C. (2025) · Highlights in Science Engineering and Technology · doi:10.54097/te6m0d54 · Cited by 1
“Daniel Muñoz-Espín et al. developed galactoside-conjugated cytotoxins exploiting senescent cell lysosomal β-galactosidase activity [76].”
Nano-Transducers Composed of Lipids Visualize Population Doubling Levels of Cells
Kimura, N., Takahashi, A., & Shinya, S. (2025) · International Conference on Solid-State Sensors, Actuators and Microsystems · doi:10.1109/transducers61432.2025.11109920
“Recent remarkable successes with lipid-based nanoparticles in drug delivery systems [1] suggest, they could contribute to senolysis [2–4]: selectively eliminating senescent cells.”
Mesoporous silica-based nanocarriers in pulmonary drug delivery
Kumar, D., & Viswalingam, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24802-3.00010-x
Does Getting Older Mean Getting a Recurrence? Assessing Aging Correctly
Klinge, U. (2025) · Springer eBooks · doi:10.1007/978-3-662-71630-4_18
Lee, H. C., Haffner, M. P., Balog, S., Taladriz‐Blanco, P., Mroczek, A., Staudinger, S., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2026) · Nanoscale · doi:10.1039/d5nr05035a · Cited by 1
“25 Despite these advances, the e ff ects of NPs on senescent cells remain largely uncharted, though their distinct physicochemical properties hold potential for a range of biomedical applications.”
Microglial senescence and senolytic drugs
Ben-Azu, B., Sabbah, S., Awogbindin, I. O., Chidebe, E. O., Oritsemuelebi, B., Patel, D., Frenkel, D., & Tremblay, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00010-3
Zhang, X., Yang, L., He, X., Zhao, M., Fang, Z., Xu, G., Duan, Z., & Luo, K. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.050 · Cited by 2
Soysouvanh, F. (2019) · theses.fr (ABES) · doi:10.70675/3890835fzb557z430aza571z697de58045dd · Cited by 1
Teissier, T. (2019) · theses.fr (ABES) · doi:10.70675/f49bc069z5ee6z4c49zb46fz0a1413dbba95
Impact of aging on cardiac mesenchymal stromal cells
Martini, H. (2019) · theses.fr (ABES) · doi:10.70675/bb7ddcb3z0b6az4c39za6eczc94e0563f0a3
Dissecting the impact of cellular senescence on muscle regeneration
Cazin, C. (2020) · theses.fr (ABES) · doi:10.70675/42a7ff38zb338z4eb8za925z2ce0a01ee74e
Characterization and impact of cellular senescence during mammary gland involution
Charifou, E. (2022) · theses.fr (ABES) · doi:10.70675/54491057z33e4z449fzb26fz6a2e42b1a22e
Senolytic drug discovery and mechanisms of action in BRAF-V600E oncogene-induced senescence
L’Hôte, V. (2022) · theses.fr (ABES) · doi:10.70675/acd5f426zc1b2z446fz8404z0f8f121081f8 · Cited by 1
Dotou, M. (2023) · theses.fr (ABES) · doi:10.70675/ea22a042z96ccz45fdz9667z82a8825cb567
Arribas‐Álvarez, I., Algar, S., Picallos-Rabina, P., Sánchez-Merino, A., Marcos‐Ramiro, B., Collado, M., Vázquez‐Villa, H., López-Rodríguez, M. L., & Benhamú, B. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00412
Han, Y., Ma, L., & Ma, X. (2026) · Biology Direct · doi:10.1186/s13062-026-00908-y · Cited by 1
Chen, F., Zhang, C., Li, Y., Khan, M. A., Pang, X., Zhu, S., & Tang, B. (2026) · Industrial Crops and Products · doi:10.1016/j.indcrop.2026.124024
Established and emerging roles of lysosomal dysfunction in cardiac aging
Santin, Y., Simon, I., Parini, A., Lezoualc’h, F., & Sommariva, E. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00853-z · Cited by 1
“Reliable quantification requires time-resolved and multiparametric analyses, which are difficult to implement in intact tissues 182 .”
Wang, G., Meng, Y., & Han, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103293
Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy
Kanbur, E., & Aydin, Ö. F. (2026) · Biogerontology · doi:10.1007/s10522-026-10489-y
Pallatt, S., Nambidi, S., Banerjee, A., & Pathak, S. (2026) · Cancer Reports · doi:10.1002/cnr2.70682
“The drug-delivery systems, including galacto-oligosaccharide encapsulation, lipofuscin-targeted dasatinib conjugates, and PEO- b-PCL micelles, dramatically diminish systemic toxicity with a pronounced increase in senescent cell targeting [177].”
Secretome and bioactive molecules for the enhancement of aged wound healing
Blanco‐Elices, C., Carvalho, D. S., Dores, R., Deus, C. M., Ramos, S., Cabral, L., Cruzeiro, C., Bimbo, L. M., & Fernandes, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103374
Du, L., Zhang, Y., Liang, R., Song, B., Zhou, J., 夏贤武, Liu, C., Wu, K., & Cao, X. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01847-x
“Galacto-encapsulated nanoparticles were shown to release cytotoxic drugs preferentially in senescent cells and to improve tumor regression when combined with palbociclib, with lower systemic toxicity [203].”
Cellular senescence: six decades of discovery and reinvention
Klaver, M., Steeneken, L. S., Veeningen, N., Altulea, A., & Demaria, M. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00922-w
Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics
Kim, H.-J., Lee, J., & Hwangbo, C. (2026) · Aging Cell · doi:10.1111/acel.70757
Huang, J., Ji, L., Jin, H., Shi, Z., Song, X., Cai, Y., & Tong, X. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103398
Iglesias-Fente, A., López-Seijas, J., Arufe, M. C., Fafián‐Labora, J., & Rey‐Rico, A. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2726650
“Among the numerous approaches that have been explored, drug (Muñoz‐Espín et al. 2018; Popov et al. 2022; Parshad et al., 2025) and gene therapy (López-Seijas et al. 2023) have emerged as the most promising alternatives capable of avoiding common off-target effects, transient efficacy, and safety…”
Targeting senescence-mediated immune resistance for enhanced tumor immunotherapy
Chen, S., Su, J., Jin, A., Liu, C., Zhang, P., Xu, Z., Pan, J., Lai, Y., & Yu, H. (2026) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2026.26
Kamil, R. M., Aramwit, P., Nyamathulla, S., & Mahmood, S. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.109026
Metadata
- Authors
- Muñoz‐Espín, D., Rovira, M., Galiana, I., Giménez, C., Lozano‐Torres, B., Paez‐Ribes, M., Llanos, S., Chaib, S., Muñoz‐Martín, M., Ucero, A. C., Garaulet, G., Mulero, F., Dann, S. G., VanArsdale, T., Shields, D. J., Bernardos, A., Murguía, J. R., Martínez‐Máñez, R., & Serrano, M.
- Affiliations
- University of Cambridge (GB)
- Spanish National Cancer Research Centre (ES)
- Universitat de València (ES)
- Pfizer (United States) (US)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Muñoz‐Espín, Daniel
- Serrano, Manuel
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2018-07-16
- Volume
- 10
- Issue
- 9
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC6127887
- OpenAlex
- W2884253843
- Cited by
- 339
- References
- 64
- Citations by year
- 2026: 33 · 2025: 48 · 2024: 52 · 2023: 45 · 2022: 48 · 2021: 28 · 2020: 52 · 2019: 31 · 2018: 2
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RiuNet (Universitat Politècnica de València) (submittedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Secretaría de Estado de Investigación, Desarrollo e Innovación (MAT2015‐64139‐C4‐1‐R)
- H2020 European Research Council
- Instituto de Salud Carlos III (DTS16/00205)
- European Regional Development Fund
- European Social Fund
- Institut Ruđer Bošković
- Fundación Botín
- Banco Santander
- “la Caixa” Foundation
- Cancer Research UK (C9685‐A25177, RG86786)
- Generalitat Valenciana (PROMETEOII/2014/047)
- Pfizer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- senolytics, senescent cells, drug delivery systems, galactooligosaccharides, lysosomal beta-galactosidase, chemotherapy-induced senescence, palbociclib, age-related diseases
- MeSH terms
- Animals, beta-Galactosidase, Cell Survival, Cytotoxins, Disease Models, Animal, Drug Compounding, Fluorescent Dyes, Galactose, Lysosomes, Neoplasm Transplantation, Neoplasms, Oligosaccharides, Piperazines, Pyridines, Staining and Labeling, Drug Delivery Systems, Cellular Senescence, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.